AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rumboldt, Z.
Right arrow Articles by Sajko, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rumboldt, Z.
Right arrow Articles by Sajko, T.

Nonenhancing Spinal Subdural Metastatic Tumor

Zoran Rumboldta, Lara Lambertb, Jasna Talan-Hranilovicc, Domagoj Marjand and Tomislav Sajkoe

a Department of Radiology, Medical University of South Carolina, Charleston, SC
b Medical University of South Carolina, Charleston, SC
c Departments of Pathology
d Radiology
e Neurosurgery, University Hospital Sestre Milosrdnice, Zagreb, Croatia (Hrvatska)



View larger version (154K):

[in a new window]
 
FIG 1. MR images of a 59-year-old woman with a hemorrhagic spinal subdural metastasis.

A, T2-weighted fast spin-echo image in the sagittal plane shows a mass (arrows) in the spinal canal that is of higher signal intensity in its central portion with peripheral hypointensity. The lesion is extramedullary and extends behind the C3 and C4 vertebral bodies, almost completely filling the spinal canal.

B, T2*-weighted midsagittal gradient-echo image shows that the mass (arrows), which has a broad base anteriorly, consistent with extramedullary origin, is predominantly hypointense, indicative of a blood clot.

C, T2*-weighted gradient-echo image in the axial plane at the C4-C5 level shows a mass (arrows) arising in the left anterior subdural space, extending into the left lateral recess, and causing severe spinal cord compression. The lesion is of mixed low and high signal intensity, indicative of partially clotted acute hemorrhage. The compressed spinal cord is hyperintense (arrowhead).

D, T2*-weighted gradient-echo image at the C3-C4 level reveals at least 2 focal areas of very low signal intensity (arrows) within the spinal cord, corresponding to hemorrhagic cord lesions.

E, Precontrast T1-weighted sagittal spin-echo image corresponding to A shows a lack of visualization of cerebrospinal fluid around the spinal cord at the C4 and C5 levels, indicating that the mass is isointense with the cord. The signal intensity pattern of this lesion is consistent with a combination of oxyhemoglobin (bright on T2-weighted images) with deoxyhemoglobin and early clot formation (dark areas on T2- and especially T2*-weighted images), corresponding to hyperacute-to-acute hemorrhage.

F, Postcontrast T1-weighted sagittal spin-echo image corresponding to E demonstrates an absence of lesion enhancement. Note the presence of contrast enhancement in the anterior epidural space at the C1-C2 level and in the pharyngeal mucosa.

G, Postcontrast axial T1-weighted spin-echo image corresponding to C shows a lack of lesion enhancement. The image is from the delayed set of postcontrast T1-weighted images acquired after postcontrast scanning of the brain. The absence of enhancement may be due to the mass effect of the hemorrhage and a relatively isolated location of the lesion. Contrast enhancement could perhaps have been observed with a higher (triple) dose of contrast agent.



View larger version (123K):

[in a new window]
 
FIG 2. Histology of a hemorrhagic spinal subdural metastasis in a 59-year-old woman.

A, Photomicrograph shows numerous small anaplastic epithelial cells with nuclear polymorphism (red arrows). These malignant cells are also present within the blood vessels (yellow arrows) (Mallory, original magnification x400).

B, Photomicrograph demonstrates strong carcinoembryonic antigen (CEA) reactivity in metastatic carcinoma cells (Immunohistochemistry for CEA, original magnification x400).